Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Income from Non-Controlling Interests: 2018-2021

Historic Income from Non-Controlling Interests for Amphastar Pharmaceuticals (AMPH) over the last 3 years, with Sep 2021 value amounting to -$1.4 million.

  • Amphastar Pharmaceuticals' Income from Non-Controlling Interests fell 261.56% to -$1.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$92,000, marking a year-over-year decrease of 101.00%. This contributed to the annual value of $1.2 million for FY2021, which is 287.25% up from last year.
  • According to the latest figures from Q3 2021, Amphastar Pharmaceuticals' Income from Non-Controlling Interests is -$1.4 million, which was down 65.15% from -$855,000 recorded in Q2 2021.
  • In the past 5 years, Amphastar Pharmaceuticals' Income from Non-Controlling Interests ranged from a high of $6.6 million in Q4 2019 and a low of -$3.0 million during Q1 2019.
  • In the last 3 years, Amphastar Pharmaceuticals' Income from Non-Controlling Interests had a median value of $424,000 in 2020 and averaged $502,636.
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Income from Non-Controlling Interests soared by 4,562.42% in 2019 and then tumbled by 261.56% in 2021.
  • Quarterly analysis of 4 years shows Amphastar Pharmaceuticals' Income from Non-Controlling Interests stood at -$149,000 in 2018, then skyrocketed by 4,562.42% to $6.6 million in 2019, then tumbled by 83.56% to $1.1 million in 2020, then slumped by 261.56% to -$1.4 million in 2021.
  • Its Income from Non-Controlling Interests was -$1.4 million in Q3 2021, compared to -$855,000 in Q2 2021 and $1.1 million in Q1 2021.